Novartis extends lead on psoriasis rivals with a pair of new Cosentyx approvals

Carly Helfand

has been working hard to rack up indications for new med before other next-gen competitors hit the scene. And now, it's accomplished that goal in the U.S.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS